About senseaboutscience

This author has not yet filled in any details.
So far senseaboutscience has created 109 blog entries.

Pharma companies launch portal to give access to trial data

An online portal where researchers can request access to anonymized patient-level clinical trial data from five pharmaceutical companies has been launched at Last year GSK was the first company to launch an online system for researchers to request access to trial data. GSK has now been joined by Roche, Boehringer Ingelheim, Sanofi and ViiV Healthcare. The five companies are inviting all […]

3rd January 2014|

Strong call for access to clinical trial information from MPs

The UK’s Public Accounts Committee has called on the Government to make sure that AllTrials’s aims – that all clinical trials, past, present and future, are registered and full methods and results available for independent scrutiny – happen. The Committee of MPs said they were surprised and concerned to discover that information on medicines is […]

3rd January 2014|

Public Accounts Committee Tamiflu investigation: a positive move for clinical trial transparency

The Public Accounts Committee has today called on the Government to ensure that full methods and results from clinical trials of all treatments currently used in the UK are available to doctors and researchers. This echoes the call of the AllTrials campaign for all clinical trials to be registered and results reported.

The Committee’s report on Access […]

3rd January 2014|

Agreement reached in Europe on Clinical Trials Regulation

Exciting news from Brussels this morning – law that would mean researchers running a clinical trial in Europe have to register the trial before it begins and to publish summary results within a year of its end is a step closer. The committee of representatives from every EU member state government has agreed with the […]

20th December 2013|

Timeline test

19th December 2013|

Clinical Trials Regulation in Europe – breaking news

This Friday 20th December the EU’s Clinical Trials Regulation will be approved by the Council of the EU. This will mark the end of the Trilogue discussions which have being on between the Council of the European Union, Parliament and Commission in Brussels. We just received this message from Glenis Willmott MEP’s office:

“Just to give you an […]

16th December 2013|

European pharmacists group puts AllTrials advert in its journal

The European Association of Hospital Pharmacists has just put an advert for the AllTrials campaign (PDF) in its journal, The European Journal of Hospital Pharmacy.

This is a fantastic idea and we encourage other organisations to follow their lead. If you’re interested in doing something similar and need information about AllTrials or graphics/logos, please get in […]

13th December 2013|

Until the results of all clinical trials are published, patients everywhere lose out

This is an article published by Wiley Exchanges on 10th December. You can read the full piece here.

The best available evidence suggests that between a third and a half of all clinical trials conducted have not gone on to be published. Worse than that, trials with positive results are about twice as likely to be […]

12th December 2013|

Withholding trial results is research misconduct says UK doctors register

Withholding clinical trial results is research misconduct the head of the register of all UK doctors told a committee of MPs yesterday. The General Medical Council  (GMC) registers doctors to practise medicine in the UK. Its Chief Executive Niall Dickson told the Health Select Committee that “It’s absolutely clear – doctors cannot do research and […]

11th December 2013|

European organisations send briefing document on Clinical Trials Regulation in Europe

Ahead of final discussions currently taking place that will decide the fate of Clinical Trials Regulation in Europe, last week thirty-eight European medical, research and patient organisations sent a briefing document (PDF) on Clinical Trials Regulation to a number of prominent European contacts.

The briefing explains the importance of retaining proposed amendments which support clinical trial […]

9th December 2013|